A bill amending the 340B statute to explicitly require drug makers to unconditionally sell and deliver 340B drugs dispensed by contract pharmacies is expected to be introduced just before or during the 340B Coalition summer conference July 10-12 near Washington,
…
Maine Gov. Janet Mills (D) signed bipartisan legislation late last week requiring 340B hospitals to submit annual reports consistent with the American Hospital Association’s voluntary 340B good stewardship principles.
The new law made Maine the second state to impose reporting
…SPONSORED CONTENT
Location: Gaylord National Resort & Convention Center
Start your 340B Coalition Summer Conference with the latest developments in the 340B program. Verity Solutions will be hosting a panel discussion at the Gaylord Resort in National Harbor with some of the most respected long-term experts on the 340B program. Join us for an up-to-the-minute report on hot button topics related to the legislative, compliance, and regulatory aspects of the 340B program.
Among the topics to be covered:
Space is limited and only open to 340B covered entities.
ASAP 340B, the nonprofit group that the brand drug industry and health centers formed to help advance the two sides’ joint plan to remake the 340B program, held its first webinar yesterday to describe its policy principles and call for
…
Q: Where did you complete your professional training?
I attended the Pharmacy Technician Program at Idaho State University.
Q: Where do you live?
Priest River, Idaho
A new “playbook” for employers on getting the upper hand with pharmacy benefit managers says PBM handling of 340B drugs is a top 10 concern for business-sponsored health plans.
Released yesterday by the Washington, D.C., based National Alliance of Healthcare
…
Two hospital groups separately urged Biden administration officials this month to not divert funding from non-340B hospitals and some 340B hospitals in order to repay other 340B hospitals for almost five years’ worth of illegal Medicare Part B drug payment
…
Hospitals that enrolled in the 340B program after its expansion in 2010 treated more commercially insured cancer patients with five commonly prescribed biologic oncology drugs and spent more on the drugs, a new JAMA study found.
The authors of
What do the outcomes of 340B policy debates in two state legislatures on opposite ends of the political spectrum mean for 340B stakeholders? 340B Report Publisher and CEO Ted Slafsky gives the most important takeaways in his latest column for
…*Sign up for news summaries and alerts from 340B Report
